Gianfranco Ferraccioli
Correspondence to Prof. Gianfranco Ferraccioli Institute of Rheumatology and Affine Sciences-Catholic University of the Sacred Heart-CIC-Viale Moscati 31-00168 Rome
Itatly; or Prof Domenico Frezza
Laboratory of Genetics
Department of Biology "Enrico Calef"
Italy;
Name/email consistency: high
- Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus. Frezza, D., Tolusso, B., Giambra, V., Gremese, E., Marchini, M., Nowik, M., Serone, E., D'Addabbo, P., Mattioli, C., Canestri, S., Petricca, L., D'Antona, G., Birshtein, B.K., Scorza, R., Ferraccioli, G. Ann. Rheum. Dis. (2012)
- Should we consider tumor necrosis factor as the only target in spondyloarthritides? Ferraccioli, G., Gremese, E. J. Rheumatol. Suppl (2012)
- Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis. Ferraccioli, G.F., Gremese, E. Swiss. Med. Wkly (2011)
- Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression. Bosello, S., Fedele, A.L., Peluso, G., Gremese, E., Tolusso, B., Ferraccioli, G. Ann. Rheum. Dis. (2011)
- Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. Ferraccioli, G., De Santis, M., Peluso, G., Inzitari, R., Fanali, C., Bosello, S.L., Iavarone, F., Castagnola, M. Autoimmun. Rev (2010)
- Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors. Ferraccioli, G., Romano, G. Lupus (2008)
- Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings. Ferraccioli, G., Tolusso, B. Autoimmun. Rev (2007)
- Pharmacogenetic of antirheumatic treatments: clinical implications. Ferraccioli, G., Tolusso, B., De Santis, M. Pharmacogenomics J. (2007)
- Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis. Ferraccioli, G., Zoli, A., Alivernini, S., De Santis, M., Verrillo, A., Loperfido, F. Nature Clinical Practice. Cardiovascular Medicine (2006)
- Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases. Ferraccioli, G.F., Tomietto, P., De Santis, M. Ann. N. Y. Acad. Sci. (2005)
- Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers. Ferraccioli, G.F., Gremese, E. Ann. Rheum. Dis. (2004)
- Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology. Ferraccioli, G., De Santis, M., Tolusso, B. Pharmacogenomics (2004)









